Sulfur mustard and respiratory diseases: Revisit with special reference to the “Comments on ‘Sulfur Mustard and Respiratory Diseases’, Tang and Loke (Citation) and a prepared Integrated Mechanism for Chronic Pulmonary Disease from Exposure to Sulfur Mustard” by Saburi and Ghanei (Citation)

References

• Aghanouri R, Ghanei M, Aslani J, et al. (2004). Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol, 287, L1160–4
   PubMed Web of Science ®Google Scholar
• Amiri S, Ghazanfari T, Yaraee R, et al. (2009). Serum levels of GM-CSF 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol, 9, 1499–503
   PubMed Web of Science ®Google Scholar
• Anand T, Vijayaraghavan R, Bansal I, Bhattacharya BK. (2009). Role of inflammatory cytokines and DNA damage repair proteins in sulfur mustard exposed mice liver. Toxicol Mech Methods, 19, 356–62
   PubMed Web of Science ®Google Scholar
• Arroyo CM, Burman DL, Sweeney RE, et al. (2004). Neutralization effects of interleukin-6 (IL-6) antibodies on sulfur mustard (HD)-induced IL-6 secretion on human epidermal keratinocytes. Environ Toxicol Pharmacol, 17, 87–94
   Google Scholar
• Arroyo CM, Kan RK, Burman DL, et al. (2003). Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells. Pharmacol Toxicol, 92, 204–13
   PubMedGoogle Scholar
• Arroyo CM, Schafer RJ, Kurt EM, et al. (2000). Response of normal human keratinocytes to sulfur mustard: cytokine release. J Appl Toxicol, 20, S63–72
   PubMed Web of Science ®Google Scholar
• Attaran D, Lari SM, Towhidi M, et al. (2010). Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 5, 335–40
   PubMedGoogle Scholar
• Bjoraker JA, Ryu JH, Edwin MK, et al. (1998). Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 157, 199–203
   PubMed Web of Science ®Google Scholar
• Blaha M, Bowers Jr W, Kohl J, et al. (2000a). Il-1-related cytokine responses of nonimmune skin cells subjected to CEES exposure with and without potential vesicant antagonists. In Vitro Mol Toxicol, 13, 99–111
   PubMedGoogle Scholar
• Blaha M, Bowers Jr W, Kohl J, et al. (2000b). Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J Appl Toxicol, 20, S101–8
   PubMedGoogle Scholar
• Costabel U, King TE. (2001). International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J, 17, 163–7
   PubMedGoogle Scholar
• Cowan FM, Broomfield CA, Smith WJ. (2002). Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol Toxicol, 18, 175–80
   PubMed Web of Science ®Google Scholar
• Emad A, Emad V. (2007a). Elevated levels of MCP-1, MIP-α and MIP-1β in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology, 240, 60–9
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. (2007b). Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol, 27, 605–12
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. (2007c). Increased granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) levels in BAL fluid from patients with sulfur mustard gas-induced pulmonary fibrosis. J Aerosol Med, 20, 352–60
   PubMedGoogle Scholar
• Emad A, Emad Y. (2007d). Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res, 27, 38–43
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. (2007e). CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation. J Inflamm (Lond), 4, 2
   PubMedGoogle Scholar
• Emad A, Rezaian GR. (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest, 112, 734–8
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. (1999). Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest, 115, 1346–51
   PubMed Web of Science ®Google Scholar
• Ghabili K, Agutter PS, Ghanei M, et al. (2011). Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol, 41, 384–403
   PubMed Web of Science ®Google Scholar
• Ghanei M, Abolmaali K, Aslani J. (2004). Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: an open-label study. Curr Ther Res, 65, 495–504
   PubMed Web of Science ®Google Scholar
• Ghanei M, Adibi I, Farhat F, Aslani J. (2008). Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chron Respir Dis, 5, 95–100
   PubMedGoogle Scholar
• Ghanei M, Harandi AA. (2007). Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol, 19, 451–6
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. (2011). Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol, 23, 363–71
   PubMed Web of Science ®Google Scholar
• Ghanei M, Khalili AR, Arab MJ, et al. (2005). Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol, 97, 302–5
   PubMed Web of Science ®Google Scholar
• Ghanei M, Panahi Y, Mojtahedzadeh M, et al. (2006). Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. Pulm Pharmacol Ther, 19, 148–53
   PubMed Web of Science ®Google Scholar
• Ghanei M, Shohrati M, Harandi AA, et al. (2007). Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol, 19, 889–94
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Ghazanfari T, Yaraee R, et al. (2012). Evaluation of the tear and serum levels of IL-8 in sulfur mustard intoxicated patients 20 years after exposure. Cutan Ocul Toxicol, 31, 132–7
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Yaraee R, Kariminia A, et al. (2009). Alterations in the serum levels of chemokines 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol, 9, 1471–6
   PubMed Web of Science ®Google Scholar
• Hosseini-khalili A, Haines DD, Modirian E, et al. (2009). Mustard gas exposure and carcinogenesis of lung. Mutat Res, 678, 1–6
   PubMed Web of Science ®Google Scholar
• Kehe K, Balszuweit F, Emmler J, et al. (2008). Sulfur mustard research – strategies for the development of improved medical therapy. Eplasty, 10, e32
   Google Scholar
• Kehe K, Balszuweit F, Steinritz D, Thiermann H. (2009). Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology, 263, 12–19
   PubMed Web of Science ®Google Scholar
• Panahi Y, Ghanei M, Aslani J, Mojtahedzadeh M. (2005). The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas. Iran J Allergy Asthma Immunol, 4, 83–90
   PubMedGoogle Scholar
• Pourfarzam S, Ghazanfari T, Yaraee R, et al. (2009). Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol, 9, 1482–8
   PubMed Web of Science ®Google Scholar
• Ricketts KM, Santai CT, France JA, et al. (2000). Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J Appl Toxicol, 20, S73–6
   PubMed Web of Science ®Google Scholar
• Sabourin CL, Danne MM, Buxton KL, et al. (2002). Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol, 16, 263–72
   PubMed Web of Science ®Google Scholar
• Saburi A, Ghanei M. (2013). Comments on “Sulfur mustard and respiratory diseases”, Tang and Loke (2012) and a prepared integrated mechanism for chronic pulmonary disease from exposure to sulfur mustard. Critical reviews in toxicology (submitted)
   Google Scholar
• Smith WJ. (2009). Therapeutic options to treat sulfur mustard poisoning – the road ahead. Toxicology, 263, 70–3
   PubMed Web of Science ®Google Scholar
• Taghaddosinejad F, Fayyaz AF, Behnoush B. (2011). Pulmonary complications of mustard gas exposure: a study on cadavers. Acta Med Iran, 49, 233–6
   Google Scholar
• Takeshima Y, Inai K, Bennett WP, et al. (1994). p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis, 15, 2075–9
   PubMed Web of Science ®Google Scholar
• Tanaka F, Dannenberg Jr AM, Higuchi K, et al. (1997). Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation, 21, 251–67
   PubMed Web of Science ®Google Scholar
• Tang, FR, Loke WK. (2012). Sulfur mustard and respiratory diseases. Crit Rev Toxicol, 42, 688–702
   PubMed Web of Science ®Google Scholar
• Tsuruta J, Sugisaki K, Dannenberg Jr AM, et al. (1996). The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation, 20, 293–318
   PubMed Web of Science ®Google Scholar
• Wormser U, Brodsky B, Proscura E, et al. (2005). Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion: effect of topical iodine. Arch Toxicol, 79, 660–70
   PubMed Web of Science ®Google Scholar
• Yaraee R, Ghazanfari T, Ebtekar M,et al. (2009). Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran cohort study. Int Immunopharmacol, 9, 1466–70
   PubMed Web of Science ®Google Scholar
• Zarin AA, Behmanesh M, Tavallaei M, et al. (2010). Overexpression of transforming growth factor (TGF)-beta1 and TGF-beta3 genes in lung of toxic-inhaled patients. Exp Lung Res, 36, 284–91
   PubMed Web of Science ®Google Scholar